Skip Nav Destination
Platelet glycoprotein receptor VI in abdominal aortic aneurysms, TP53 mutations in 5q-deleted myelodysplastic syndrome, and immunostimulatory cytokine plus CAR T-cell therapy in acute lymphoblastic leukemia
Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma
